SCHEMBL5585735

SCHEMBL5585735

CCC1(C)CCCN1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15426524 1.00
SCHEMBL28142684 0.93 SLC6A4 (0.34)
SCHEMBL24308462 0.84
SCHEMBL5585336 0.79 KDM4E (0.31)
SCHEMBL6658044 0.78
SCHEMBL24718527 0.78
SCHEMBL25349071 0.78
SCHEMBL13448668 0.78
Iodide SCHEMBL28867004 0.76 EHMT2 (0.32)
SCHEMBL3801077 0.76 SLC6A4 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836238-A1 FUNCTIONALIZED POLYMERS AND IMPROVED TIRES THEREFROM Bridgestone Corporation (JP) 2007-09-26 EP claimed
WO-2006076629-A1 FUNCTIONALIZED POLYMERS AND IMPROVED TIRES THEREFROM BRIDGESTONE CORPORATION (JP) 2006-07-20 WO claimed
US-20120323003-A1 TETRAHYDROISOQUINOLINE SULFONAMIDE DERIVATIVES, THE PREPARATION THEREOF, AND THE USE OF THE SAME IN THERAPEUTICS SANOFI (FR) 2012-12-20 US disclosed
US-20110269700-A1 GLUCOSIDE DERIVATIVES AND USES THEREOF NOVARTIS AG 2011-11-03 US disclosed